Newsletter insight
US$213 Million Vaccine Manufacturing Investment Targets Lusaka
Perspectives from the HPC business newsletter.
← All business news
The joint venture between Zambia's Industrial Development Corporation and China's Jijia includes plans for a vaccine manufacturing facility in Lusaka. The investment adds to industrial development activity and may support demand for specialised commercial and...
The joint venture between Zambia's Industrial Development Corporation and China's Jijia includes plans for a vaccine manufacturing facility in Lusaka. The investment adds to industrial development activity and may support demand for specialised commercial and industrial facilities.
Developers, construction contractors, architects and property consultants can explore potential demand for industrial buildings, utilities, warehousing and supporting infrastructure. Opportunities will depend on project implementation and procurement plans.